Essa Pharma (EPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 91,683 | 35,345 | 33,702 | 38,467 | 44,301 |
| Marketable Securities | 44,206 | 106,775 | 114,375 | 114,002 | 112,743 |
| Receivables | 215 | 181 | 135 | 133 | 9 |
| TOTAL | $137,298 | $143,869 | $148,797 | $153,290 | $158,114 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 598 | 620 | 325 | 360 | 390 |
| TOTAL | $598 | $620 | $325 | $360 | $390 |
| Total Assets | $137,896 | $144,489 | $149,122 | $153,650 | $158,504 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,074 | 3,432 | 3,415 | 3,296 | 2,021 |
| TOTAL | $4,174 | $3,531 | $3,495 | $3,408 | $2,147 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 253 | 275 | 0 | 0 | 20 |
| TOTAL | $253 | $275 | $N/A | $N/A | $20 |
| Total Liabilities | $4,427 | $3,806 | $3,495 | $3,408 | $2,166 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,363 | 44,238 | 44,142 | 44,101 | 44,092 |
| Common Shares | 279,680 | 278,511 | 278,162 | 278,142 | 278,142 |
| Retained earnings | -194,415 | -185,426 | -179,461 | -173,980 | -166,681 |
| Other shareholders' equity | -2,101 | -2,100 | -2,120 | -2,122 | -2,165 |
| TOTAL | $133,469 | $140,683 | $145,627 | $150,243 | $156,338 |
| Total Liabilities And Equity | $137,896 | $144,489 | $149,122 | $153,650 | $158,504 |